Clinical Trial Update: Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous tolerogenic dendritic cells for highly sensitized kidney transplant recipients; the study is currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Autologous tolerogenic dendritic cells (ATDC)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Kidney Transplant Rejection | Phase 1 | Status: NOT_YET_RECRUITING